For many around the world, climate change has never felt so real as firestorms, floods and other natural disasters have shook the developed world in recent years. The problem is fossil fuels, and that problem is coming home to roost. Industry and automobiles are one source of mankind’s oil addiction, but plastics are another. So what can pharma do to help? This week we look to one answer from Novo Nordisk, who are piloting an approach to recycle millions of injection pens in the UK that otherwise would have gone to landfill.
 
Weekly Spotlight

Drug developers must balance speed, performance, and quality when developing new protein therapeutics. Sartorius’ reliable cell line development services minimize your risk and timeline, maximize the performance of your cell line and save your resources. Derisk your decision-making and let our team with over 14 years of experience expand your capabilities. Learn more...
 
BUSINESS PRACTICE
Inside the PenCycle Recycling Scheme
01/25/2022
Novo Nordisk explains how its pilot scheme in the UK is helping to recycle injector pens.
CLINICAL TRIALS
Keeping It Real
01/24/2022 | Karen Ooms
Why the industry needs to finally wake up to the real-life benefits of real-world data.
STANDARDS & REGULATION
Who’s the Coolest?
01/26/2022 | Angus Stewart
A best practice competition developed to encourage labs to pursue more efficient cold storage is now on for 2022.
DRUG DISCOVERY
Allergy Relief
01/21/2022 | Maryam Mahdi
Allergies pose a significant challenge to patients worldwide. How can we use novel immunotherapy approaches to lessen their therapeutic burden?
 
Webinars: On Demand

Evolution of Analytical Techniques for Biopharmaceutical Drug Development
Available On-Demand

Critical Quality Attributes for supply of clinical plasmids for cell and gene therapy development
Available On-Demand

The side-effects of bad data in API development and manufacture
Available On-Demand
 
App Notes
Intensifying Upstream Processing and the Implications for Media Management

Your upstream bioprocess media journey does not end when it enters the bioreactor. Find out how to implement good media management throughout your bioprocess and avoid the common pitfalls. Download our whitepaper now.
In vitro bioequivalence studies for oral solid dose products

The Morphologi® ID can be used to compare material and chemical properties of Active Pharmaceutical Ingredients (APIs) in a drug product using Morphologically-Directed Raman Spectroscopy (MDRS®). Read more
Exploring the Value of GPC/SEC in Polysaccharide Characterization

The properties of polymeric excipients can directly affect the clinical efficacy, safety, and quality of a finished pharmaceutical product and are routinely identified as critical quality attributes (CQAs). Read more
 
Special Promotions
Analyze NMR & LC/MS Data From All Data Formats in One Software Application

Process your data, assign chemical structures, make digital annotations, get help with structure verification, and report results. Do this for all analytical experiments, in all major data formats! Learn more...
Download Our Special Supplement on Cell and Gene Therapies

What lies ahead for cell and gene therapies? The field and its research continue to expand, but one key topic is tackling solid tumors. Download our supplement to learn more.
Nominations for The Medicine Maker 2022 Power List are now open!

Who in the drug development and manufacturing industry do you feel deserves a spot in this prestigious list? Nominate today! Learn more...
Watch Our Video Interview With Johnson Matthey’s Nick Shackley

Nick Shackley from Johnson Matthey shares his insight on the trends and challenges affecting the pharma industry, with a focus on generics and the increasing molecular complexity of drugs. Learn more...
Watch Our Video Interview With Vetter’s Peter Soelkner

We speak with Peter Soelkner, Managing Director at Vetter, to learn about his career at the company and his views on the injectable drug segment, including trends, challenges, and more. Learn more...
Help us provide better content for you! Take our Readership Survey today

The Medicine Maker is committed to providing you with content that is relevant and of the highest quality. Tell us what you think in our short survey and you could win a $100 Amazon voucher! Learn more...
 
Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.
Find out more
This email was sent to {~email~} by info@themedicinemaker.com. To ensure delivery of emails to your inbox, please add info@themedicinemaker.com to your address book or safe sender list. To view online, please click here.

Create or manage your account here
Unsubscribe here

The Medicine Maker is a brand of Texere Publishing Limited (trading as Conexiant)

Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.